Why Delta Lithium, Liontown, Pact, and Starpharma shares are storming higher

These ASX shares are rising despite the market weakness.

| More on:
A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a disappointing day for the S&P/ASX 200 Index (ASX: XJO). In afternoon trade, the benchmark index is down 0.8% to 7,147 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

Delta Lithium Ltd (ASX: DLI)

The Delta Lithium share price is up over 3% to 76.5 cents. This morning, analysts at Bell Potter retained their speculative buy rating and $1.35 price target on the lithium explorer's shares. Its analysts aren't ruling out a takeover by Mineral Resources Ltd (ASX: MIN) in the future after the mining giant boosted its stake to 17.44%.

Liontown Resources Ltd (ASX: LTR)

The Liontown share price is up 1.5% to $3.05. Investors have been buying this lithium developer's shares after it announced the appointment of Monadelphous Group Ltd (ASX: MND) for the $100 million vertically integrated wet plant Structural, Mechanical, Piping and Electrical and Instrumentation contract. This is the last major construction contract and means Liontown remains on course to commence production in the middle of next year.

Pact Group Holdings Ltd (ASX: PGH)

The Pact Group share price is up 6% to 71.5 cents. This has been driven by news that its major shareholder, Kin Group, intends to make an unconditional 68 cents cash per share off-market takeover offer. With its shares rising beyond this level, it seems that some investors believe a better offer will be coming.

Starpharma Holdings Ltd (ASX: SPL)

The Starpharma share price is up 36% to 17.7 cents. Investors have been scrambling to buy the biotech company's shares after it released positive interim results from its phase 1/2 clinical trial of DEP irinotecan. The data shows encouraging durable signs of efficacy combined with excellent tolerability.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Starpharma. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »